Insider Transactions in Q2 2024 at Editas Medicine, Inc. (EDIT)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 04
2024
|
Baisong Mei EVP, CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
511
-0.36%
|
$2,555
$5.5 P/Share
|
|
Jun 04
2024
|
Gilmore Neil O'Neill CEO |
SELL
Open market or private sale
|
Direct |
12,191
-3.72%
|
$60,955
$5.5 P/Share
|
|
May 20
2024
|
Erick Lucera EVP, CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
22,337
-16.05%
|
$111,685
$5.61 P/Share
|
|
May 13
2024
|
Jessica Hopfield Director |
BUY
Open market or private purchase
|
Direct |
45,000
+39.93%
|
$225,000
$5.64 P/Share
|